Follow-up: Important Change to RBHS Sponsored Research and Programs Submissions and Awards

Dear Colleagues,

In follow-up to my email communication on April 27, 2022, please note the following updates:

As of July 1, 2022, all RBHS sponsored research and program activity must be submitted under a new RBHS consolidated UEI number, YVVTQD8CJC79 (associated with the RBHS institutional profile and Rutgers University EIN#1226001086).   

  • Effective 07/01/2022, ALL new RBHS submissions and awards (including competitive renewals) will use the UEI number: YVVTQD8CJC79 associated with the Rutgers EIN (tax ID number), and the RBHS EIN -- and all 8 of its associated DUNS/UEI numbers -- may no longer be used for new submissions and awards.
  • After 07/01/2022, ALL existing NIH awards (and noncompetitive renewals) will go through a Type 7 administrative “Change of Institution Request” migration on their anniversary date.
  • The process for migrating ALL other existing awards is still being developed. Please stay tuned for more information and further instructions.
  • RBHS investigators should continue to submit proposals through the Chancellor-led unit (RBHS or RU-NB) that will be administering the award.

Please Note: The Ernest Mario School of Pharmacy (EMSOP), currently using the Rutgers University–New Brunswick (RU-NB) DUNS#001912864/ UEI#M1LVPE5GLSD9, will discontinue use of the RU-NB numbers and will use the new RBHS UEI number: YVVTQD8CJC79, as above.

Research and Sponsored Programs (RSP) in the Rutgers University Office for Research (OFR) is leading the transition to the new RBHS identifiers. Please do not reach out to the sponsor agencies with questions. Work directly with your RSP Contract / Grant Specialist to address any concerns.

In preparation for the conversion to the consolidated RBHS UEI, the RAPSS portal will be taken off-line beginning on Thursday, June 16th at 6:00pm, and the system will be available again for general use on Monday, June 20th.

More detailed information about the transition will be posted on the OFR website, along with answers to frequently asked questions (FAQs), here:

If you have specific questions, that are not already addressed in the posted FAQs, please email your question(s)

Thank you for your attention to this matter.


Bishr Omary, MD, PhD
Senior Vice Chancellor for Academic Affairs and Research
Rutgers Biomedical and Health Sciences